Published • loading... • Updated
JAMA Network Open publishes Red Light’s trial of psilocybin in cocaine use disorder - BioTuesdays
Summary by biotuesdays.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
JAMA Network Open publishes Red Light’s trial of psilocybin in cocaine use disorder - BioTuesdays
Red Light Holland (CSE: TRIP; FSE: 4YX; OTCQB: TRUFF) has highlighted the publication of a peer-reviewed randomized clinical trial in the Journal of American Medical Association (JAMA) Network Open evaluating a single dose of psilocybin in adults with cocaine use disorder. According to Red Light, following its acquisition of Filament Health, the company has expanded its pharmaceutical-grade manufacturing, regulatory, and clinical research capabi…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
